N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride

C19H26ClN3O4 — CID 154894211

IUPACN-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride
SMILESCO[C@H]1[C@H](NC(=O)CN2CCOC2=O)c2ccccc2C12CCNCC2.Cl
InChIInChI=1S/C19H25N3O4.ClH/c1-25-17-16(21-15(23)12-22-10-11-26-18(22)24)13-4-2-3-5-14(13)19(17)6-8-20-9-7-19;/h2-5,16-17,20H,6-12H2,1H3,(H,21,23);1H/t16-,17+;/m1./s1
InChIKeyHQLGRRYFBLMMPF-PPPUBMIESA-N
MW395.89 g/mol
LogP1.37
Rot. Bonds4

About N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride

N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride (PubChem CID 154894211) has the molecular formula C19H26ClN3O4 and a molecular weight of 395.89 g/mol. Its IUPAC name is N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride.

Molecular Properties

Compound NameN-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride
PubChem CID154894211
Molecular FormulaC19H26ClN3O4
Molecular Weight395.89 g/mol
Exact Mass395.16
IUPAC NameN-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride
SMILESCO[C@H]1[C@H](NC(=O)CN2CCOC2=O)c2ccccc2C12CCNCC2.Cl
InChIInChI=1S/C19H25N3O4.ClH/c1-25-17-16(21-15(23)12-22-10-11-26-18(22)24)13-4-2-3-5-14(13)19(17)6-8-20-9-7-19;/h2-5,16-17,20H,6-12H2,1H3,(H,21,23);1H/t16-,17+;/m1./s1
InChIKeyHQLGRRYFBLMMPF-PPPUBMIESA-N
XLogP1.37
TPSA79.90 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500395.89
LogP ≤ 51.37
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride?
The IUPAC name of N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride (CID 154894211) is N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride.
What is the SMILES notation for N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride?
The canonical SMILES for N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride is CO[C@H]1[C@H](NC(=O)CN2CCOC2=O)c2ccccc2C12CCNCC2.Cl.
What is the InChIKey of N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride?
The InChIKey is HQLGRRYFBLMMPF-PPPUBMIESA-N. The full InChI is InChI=1S/C19H25N3O4.ClH/c1-25-17-16(21-15(23)12-22-10-11-26-18(22)24)13-4-2-3-5-14(13)19(17)6-8-20-9-7-19;/h2-5,16-17,20H,6-12H2,1H3,(H,21,23);1H/t16-,17+;/m1./s1.
What are the key properties of N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride?
N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride has a molecular weight of 395.89 g/mol, XLogP of 1.37, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R,2R)-2-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide;hydrochloride is sourced from PubChem (CID 154894211), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).